Freshpet, Inc. FRPT reported mixed first-quarter 2025 results, wherein the top line surpassed the Zacks Consensus Estimate and increased year over year. However, the bottom line missed the consensus estimate and decreased year over year. The company also revised its 2025 guidance downward. FRPT’s Quarterly Performance: Key Metrics & Insights Freshpet reported earnings per share of 9 cents, which decreased from 21 cents in the same quarter last year. The metric missed the Zacks Consensus Estimate of 13 cents. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) FRPT reported consolidated net sales of $263.2 million, beating the Zacks Consensus Estimate of $259 million. Net sales increased 17.6% from $223.8 million in the year-ago period. This growth was mainly attributed to a 14.9% increase in volume and a 2.7% improvement in the price/mix. Freshpet, Inc. Price, Consensus and EPS SurpriseFreshpet, Inc. Price, Consensus and EPS Surprise Freshpet, Inc. price-consensus-eps-surprise-chart | Freshpet, Inc. Quote Freshpet’s adjusted gross profit increased 18.5% year over year to $120.2 million. The adjusted gross margin expanded 40 basis points (bps) to 45.7% from 45.3% in the first quarter of fiscal 2024. This improvement was driven by lower input costs and reduced quality expenses, which were fully offset by decreased leverage on plant costs. Adjusted SG&A expenses rose 19.5% year over year to $84.7 million in the quarter. As a percentage of net sales, adjusted SG&A expenses increased 50 bps year over year to 32.2%. This increase was primarily driven by higher media spend as a percentage of net sales, partially offset by lower logistics costs than net sales. The adjusted EBITDA was $35.5 million, up 16.2% from $30.6 million in the year-ago period. This rise was driven by a higher adjusted gross profit, partially offset by increased adjusted SG&A expenses. FRPT Stock Past Three-Month PerformanceZacks Investment Research Image Source: Zacks Investment Research Freshpet’s Financial Health Snapshot FRPT exited the quarter with cash and cash equivalents of $243.7 million, total debt of $395.7 million, net of $6.8 million in unamortized debt issuance costs. Cash provided by operations for the quarter was $4.8 million, down $0.6 million from the same period in the prior year. Capital spending for the fiscal first quarter was $26.5 million. Capital expenditure is projected to be $225 million in 2025 compared with the $250 million mentioned earlier. What to Expect From FRPT in 2025 For 2025, the company is revising its guidance. It expects net sales of $1.12-$1.15 billion, indicating an increase of 15-18% from the 2024 actual, compared with the previously stated $1.18-$1.21 billion, which suggested an increase of 21-24%. Adjusted EBITDA is expected to be $190-$210 million, down from the prior mentioned $210 million. The company recorded adjusted EBITDA of $161.8 million in 2024. In the past three months, this Zacks Rank #5 (Strong Sell) company’s stock has lost 46.2% against the industry’s growth of 1%. Story Continues Stocks to Consider We have highlighted three better-ranked stocks, namely Nomad Foods Ltd. NOMD, United Natural Foods, Inc. UNFI and Canada Goose GOOS. Nomad Foods manufactures and distributes frozen foods. NOMD presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for NOMD’s current financial-year sales and earnings indicates growth of 7% and 11.4%, respectively. Nomad Foods delivered a trailing four-quarter earnings surprise of 5%, on average. United Natural is the leading distributor of natural, organic and specialty food and non-food products. It currently carries a Zacks Rank of 2 (Buy). UNFI delivered a trailing four-quarter earnings surprise of 408.7%, on average. The consensus estimate for United Natural’s current financial-year sales and earnings indicates growth of 1.9% and 485.7%, respectively, from the year-ago period’s reported figures. Canada Goose is a global outerwear brand. GOOS is a designer, manufacturer, distributor and retailer of premium outerwear for men, women and children. It carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for GOOS’s current fiscal year’s earnings and revenues implies declines of 1.4% and 4.9%, respectively, from the year-ago actuals. Canada Goose delivered a trailing four-quarter average earnings surprise of 71.3%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Freshpet, Inc. (FRPT):Free Stock Analysis Report United Natural Foods, Inc. (UNFI):Free Stock Analysis Report Canada Goose Holdings Inc. (GOOS):Free Stock Analysis Report Nomad Foods Limited (NOMD):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Freshpet Misses Earnings Estimates in Q1, Lowers 2025 Guidance
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...